Research results have expiration dates: Ensuring timely systematic reviews

Journal of Evaluation in Clinical Practice

Volumn 12, Issue 4, 2006, Pages 454-462

  Barroso, Julie ^a,c   Sandelowski, Margarete ^b   Voils, Corrine I ^c  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiretroviral medication adherence; Clinical relevance; HIV AIDS; Quantitative research; Systematic reviews

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

COST BENEFIT ANALYSIS; EXPIRATION DATE; GASTROINTESTINAL SYMPTOM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL RESEARCH; NEUROLOGIC DISEASE; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TIME; TOXICITY;

HUMANS; META-ANALYSIS; META-ANALYSIS AS TOPIC; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; REVIEW LITERATURE; REVIEW LITERATURE AS TOPIC; TIME FACTORS;

EID: 33746385852     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00729.x     Document Type: Review

References (53)

1. Abel E. & Painter L. (2003) Factors that influence adherence to HIV medications: perceptions of women and health care providers. Journal of the Association of Nurses in AIDS Care 14, 61-69.
2. Deeks J.J., Higgins J.P.T. & Altman D.G. (eds) (2005) Analyzing and presenting results. In Cochrane Handbook for Systematic Reviews of Interventions (version 4.2.5, Section 8) (eds J.P.T. Higgins & S. Green), John Wiley and Sons, Chichester. Available at: http://www.cochrane.org/resources/handbook/ hbook.htm (last accessed 15 January 2006).
3. Department of Health and Human Services. (2005) Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Available at: http://www.aidsinfo.nih.gov/Guidelines (last accessed 20 December 2005).
4. Douglass J.L., Sowell R.L. & Phillips K.D. (2003) Using Peplau's theory to examine the psychosocial factors associated with HIV-infected women's difficulty in taking their medications. Journal of Theory Construction & Testing 7, 10-17.
5. Durante A.J., Bova C.A., Fennie K.P., et al. (2003) Home-based study of anti-HIV drug regimen adherence among HIV-infected women: feasibility and preliminary results. AIDS Care 15, 103-115.
6. Erlen J.A., Sereika S.M., Cook R.L. & Hunt S.C. (2002) Adherence to antiretroviral therapy among women with HIV infection. Journal of Obstetric, Gynecologic, and Neonatal Nursing 31, 470-477.
7. Feigel C.A. (2003) Stress, coping, and medication adherence among HIV infected mothers. Unpublished doctoral dissertation. University of Southern California, Los Angeles, CA.
8. Fourney A.M. (1999) Adherence to HIV/AIDS therapies among low-literacy populations: the ALP project. Unpublished doctoral dissertation. University of Texas-Houston Health Science Center, Houston, TX.
9. Gant L.M. & Welch L.A. (2004) Voices less heard: HIV-positive African American women, medication adherence, sexual abuse and self-care. Journal of HIV/AIDS & Social Services 3, 67-91.
10. Garcia-Teague L.A. (2002) Factors associated with appointment and medication adherence in low-income Latinas living with the human immunodeficiency virus. Unpublished doctoral dissertation. University of California, Los Angeles, CA.
11. Glasziou P.P. & Sanders S.L. (2002) Investigating causes of heterogeneity in systematic reviews. Statistics in Medicine 21, 1503-1511.
12. Higgins J.P.T. & Green S. (eds) (2005) Cochrane handbook for systematic reviews of interventions (4.2.5). Available at: http://www.cochrane. org/resources/handbook/hbook.htm (last accessed 15 January 2006).
13. Hirokawa D. (2003) Women, HIV/AIDS and poverty: an examination of the efficacy of an AIDS drug assistance program in the state of Nevada. Unpublished Masters thesis. University of Nevada, Reno, NV.
14. Ho D.D. (1995) Time to hit HIV, early and hard. New England Journal of Medicine 333, 450-451.
15. Howard A.A., Arnsten J.H., Lo Y., et al. (2002) A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS 16, 2175-2182.
16. Ickovics J.R., Wilson T.E., Royce R.A., et al. (2002) Prenatal and postpartum zidovudine adherence among pregnant women with HIV: results of a MEMS substudy from the Perinatal Guidelines Evaluation Project. Journal of Acquired Immune Deficiency Syndromes 30, 311-315.
17. Jones D.L., Ishii M., LaPerriere A., et al. (2003) Influencing medication adherence among women with AIDS. AIDS Care 15, 463-474.
18. Kalichman S.C., Rompa D., DiFonzo K., et al. (2001) HIV treatment adherence in women living with HIV/AIDS: research based on the Information-Motivation-Behavioral Skills Model of Health Behavior. Journal of the Association of Nurses in AIDS Care 12, 58-67.
19. Laine C., Newschaffer C.J., Zhang D., Cosler L., Hauck W.W. & Turner B.J. (2000) Adherence to antiretroviral therapy by pregnant women infected with Human Immunodeficiency Virus: a pharmacy claims-based analysis. Obstetrics and Gynecology 95, 167-173.
20. Macilwain C. (1993) Physicians not fazed by AZT guidelines. Nature 364, 93.
21. Mann T. (2001) Effects of future writing and optimism on health behaviors in HIV-infected women. Archives of Behavioral Medicine 23, 26-33.
22. Mellins C.A., Havens J.F., McCaskill E.O., Leu C.S., Brudney K. & Chesney M.A. (2002) Mental health, substance use and disclosure are significantly associated with the medical treatment adherence of HIV-infected mothers. Psychology, Health & Medicine 7, 451-460.
23. Mellins C.A., Kang E., Leu C.S., Havens J.F. & Chesney M.A. (2003) Longitudinal study of mental health and psychosocial predictors of medical treatment adherence in mothers living with HIV disease. AIDS Patient Care and STDs 17, 407-416.
24. Misener T.R. & Sowell R.L. (1998) HIV infected women's decisions to take antiretrovirals. Western Journal of Nursing Research 20, 431-447.
25. Mostashari F., Riley E., Selwyn P. & Altice F.L. (1998) Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. Journal of Acquired Immune Deficiency Syndrome 18, 341-348.
26. Murphy D.A., Greenwell L. & Hoffman D. (2002) Factors associated with antiretroviral adherence among HIV-infected women with children. Women and Health 36, 97-111.
27. Nguyen P.V. (2000) Ensuring drug compliance in HIV+ female offenders in a correctional facility. Unpublished Master's thesis. The University of Texas Medical Branch at Galveston, Galveston, TX.
28. Patania S.S. (2003) Use of antiretrovirals and PCP prophylaxis in HIV positive urban women with depressive symptoms: the HERS Study. Unpublished doctoral dissertation. Johns Hopkins University, Baltimore, MD.
29. Paterson D.L., Swindells S. & Mohr J., et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine 133, 21-30.
30. Phillips K.D., Moneyham L., Murdaugh C., et al. (2005) Sleep disturbance and depression as barriers to adherence. Clinical Nursing Research 14, 273-293.
31. Popay J (ed.) (2006) Moving beyond Effectiveness in Evidence Synthesis: Methodological Issues in the Synthesis of Diverse Sources of Evidence. National Institute for Health and Clinical Excellence, London.
32. Powell-Cope G.M., White J., Henkelman E.J. & Turner B.J. (2003) Qualitative and quantitative assessments of HAART adherence of substance-abusing women. AIDS Care 15, 239-249.
33. Richter D.L., Sowell R.L. & Pluto D.M. (2002) Attitudes toward antiretroviral therapy among African American women. American Journal of Health Behavior 26, 25-33.
34. Roberts K.J. & Mann T. (2000) Barriers to antiretroviral medication adherence in HIV-infected women. AIDS Care 12, 377-386.
35. Roberts K.J. & Mann T. (2003) Adherence to antire troviral medications in HIV/AIDS care: a narrative exploration of one woman's foray into intentional non-adherence. Health Care for Women International 24, 552-564.
36. Sandelowski M., Voils C.I. & Barroso J. (2005) Integrating Qualitative & Quantitative Research Findings. National Institute of Nursing Research, National Institutes of Health, 5R01NR004907, 3 June 2005-31 March 2010.
37. Sander L. & Kitcher H. (2006) Systematic and Other Reviews: Terms and Definitions Used by UK Organizations and Selected Databases. Systematic Review and Delphi Survey. National Institute for Health and Clinical Excellence, London.
38. Sankar A., Luborsky M., Schuman P. & Roberts G. (2002) Adherence discourse among African American women taking HAART. AIDS Care 14, 203-218.
39. Schrimshaw E.W., Siegel K. & Lekas H.M. (2005) Changes in attitudes towards antiretroviral medication: a comparison of women living with HIV/AIDS in the pre-HAART and HAART eras. AIDS and Behavior 9, 267-279.
40. Schuman P., Ohmit S.E., Cohen M.H., et al. (2001) Prescription of and adherence to antiretroviral therapy among women with AIDS. AIDS and Behavior 5, 371-378.
41. Sharpe T.T., Lee L.M., Nakashima A.K., Elam-Evans L.D. & Fleming P.L. (2004) Crack cocaine use and adherence to antiretroviral treatment among HIV-infected Black women. Journal of Community Health 29, 117-127.
42. Siegel K. & Gorey E. (1997) HIV-infected women: barriers to AZT use. Social Science and Medicine 45, 15-22.
43. Siegel K., Lekas H.M., Schrimshaw E.W. & Johnson J.K. (2001) Factors associated with HIV-infected women's use or intention to use AZT during pregnancy. AIDS Education and Prevention 13, 189-206.
44. Sowell R.L., Phillips K.D., Murdaugh C. & Tovokali A. (1999) Health care providers' influence on HIV-infected women's beliefs and intentions related to AZT therapy. Clinical Nursing Research 8, 336-354.
45. Sowell R.L., Murdaugh C.L., Addy C., Moneyham L., Tavokoli A. & Misener T. (2001a) Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy. Southern Medical Journal 94, 1177-1184.
46. Sowell R.L., Phillips K.D., Seals B.F., Misener T.R. & Rush C. (2001b) HIV-infected women's experiences and beliefs related to AZT therapy during pregnancy. AIDS Patient Care and STDs 15, 201-209.
47. Stone V.E., Hogan J.W., Schuman P., et al. (2001) Antiretroviral regimen complexity, self-reported adherence, and HIV patients' understanding of their regimens: survey of women in the HER study. Journal of Acquired Immune Deficiency Syndromes 28, 124-131.
48. Thorne S., Paterson B., Acorn S., Canam C., Joachim G. & Jillings C. (2002) Chronic illness experience: insights from a metastudy. Qualitative Health Research 12, 437-452.
49. Turner B.J., Newschaffer C.J., Zhang D., Cosler L. & Hauck W.W. (2000) Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Medical Care 38, 911-925.
50. Wilson T.E., Ickovics J.R., Fernandez M.I., Koenig L.J., Walter E. (2001) Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus in four US states. American Journal of Obstetrics and Gynecology 184, 1235-1240.
51. Wilson T.E., Barrón Y., Cohen M., et al. (2002) Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clinical Infectious Diseases 34, 529-534.
52. Wood S.A., Tobias C. & McCree J. (2004) Medication adherence for HIV positive women caring for children: in their own words. AIDS Care 16, 909-913.
53. Wyatt G.E., Longshore D., Chin D., et al. (2004) The efficacy of an integrated risk reduction intervention for HIV-positive women with child sexual abuse histories. AIDS and Behavior 8, 453-462.